Page last updated: 2024-08-23

preclamol and Schizophrenia

preclamol has been researched along with Schizophrenia in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19901 (20.00)18.7374
1990's2 (40.00)18.2507
2000's2 (40.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Carlsson, A; Carlsson, ML; Nilsson, M1
Chen, R; Johnson, JL; Jordan, S; Kambayashi, J; Kikuchi, T; Kitagawa, H; McQuade, R; Regardie, K; Tadori, Y1
Carlsson, A; Corey, PK; Lahti, AC; Lahti, RA; Tamminga, CA; Weiler, MA1
Carlsson, A; Cascella, NG; Lahti, RA; Lindberg, M; Tamminga, CA1
Carnoy, P; Puech, AJ; Simon, P; Soubrie, P1

Reviews

1 review(s) available for preclamol and Schizophrenia

ArticleYear
Schizophrenia: from dopamine to glutamate and back.
    Current medicinal chemistry, 2004, Volume: 11, Issue:3

    Topics: Animals; Antipsychotic Agents; Aripiprazole; Disease Models, Animal; Dopamine; Dopamine Agonists; Dopamine Antagonists; Excitatory Amino Acid Antagonists; Glutamic Acid; Mice; Piperazines; Piperidines; Quinolones; Schizophrenia

2004

Trials

2 trial(s) available for preclamol and Schizophrenia

ArticleYear
Antipsychotic properties of the partial dopamine agonist (-)-3-(3-hydroxyphenyl)-N-n-propylpiperidine(preclamol) in schizophrenia.
    Biological psychiatry, 1998, Jan-01, Volume: 43, Issue:1

    Topics: Adult; Antiparkinson Agents; Antipsychotic Agents; Cross-Over Studies; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Female; Humans; Male; Middle Aged; Piperidines; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology

1998
Pharmacologic properties of (-)-3PPP (preclamol) in man.
    Journal of neural transmission. General section, 1992, Volume: 88, Issue:3

    Topics: Administration, Oral; Adult; Chromatography, Gas; Dopamine Agents; Double-Blind Method; Half-Life; Humans; Injections, Intramuscular; Male; Piperidines; Psychiatric Status Rating Scales; Schizophrenia; Schizophrenic Psychology

1992

Other Studies

2 other study(ies) available for preclamol and Schizophrenia

ArticleYear
In vitro functional characteristics of dopamine D2 receptor partial agonists in second and third messenger-based assays of cloned human dopamine D2Long receptor signalling.
    Journal of psychopharmacology (Oxford, England), 2007, Volume: 21, Issue:6

    Topics: Animals; Antipsychotic Agents; Aripiprazole; Calcium Signaling; CHO Cells; Cloning, Molecular; Cricetinae; Cricetulus; Dopamine; Dopamine Agonists; Dopamine Antagonists; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Humans; Immunoblotting; Lisuride; MAP Kinase Signaling System; Microscopy, Confocal; Mitogen-Activated Protein Kinase 1; Phosphorylation; Piperazines; Piperidines; Quinolones; Raclopride; Receptors, Dopamine D2; Schizophrenia; Time Factors; Transfection

2007
Performance deficit induced by low doses of dopamine agonists in rats. Toward a model for approaching the neurobiology of negative schizophrenic symptomatology?
    Biological psychiatry, 1986, Volume: 21, Issue:1

    Topics: Amisulpride; Animals; Antipsychotic Agents; Apomorphine; Disease Models, Animal; Male; Phenothiazines; Pimozide; Piperidines; Rats; Rats, Inbred Strains; Receptors, Dopamine; Reinforcement Schedule; Reinforcement, Psychology; Schizophrenia; Schizophrenic Psychology; Sulpiride

1986